COPENHAGEN — Novo Nordisk confirmed Wednesday that 400,000 prescriptions were purchased by commercial real estate firms to reduce square footage requirements per employee. Landlords now distribute GLP-1 agonists instead of leasing additional floor space. "Biology is the only overhead we can downsize," said Lars Jensen, Chief Efficiency Officer. "Health is secondary to load-bearing capacity."